[Measuring disease activity for rheumatoid arthritis]

Area of Science:

• Rheumatology
• Clinical Immunology
• Internal Medicine

Background:

• Rheumatoid arthritis (RA) is a prevalent systemic inflammatory joint disease.
• Effective treatment relies on disease-modifying antirheumatic drugs and frequent therapeutic adjustments based on disease activity.
• Current strategies emphasize consistent treatment and regular evaluation of disease activity.

Purpose of the Study:

• To review instruments and measures for assessing rheumatoid arthritis (RA) disease activity.
• To provide an overview of core set measures and composite measures used in RA assessment.
• To discuss the ongoing research agenda for RA disease activity assessment.

Main Methods:

• Review of existing literature on RA disease activity assessment tools.
• Categorization of assessment instruments into core set measures and composite measures.
• Discussion of various scales, biomarkers, functional assessments, indices, and self-assessment tools.

Main Results:

• Core set measures include joint count scales, global scales, pain scales, biomarkers, and functional assessments.
• Composite measures encompass activity indices, self-assessment tools, and response criteria.
• RA research is extensive, with instruments often adapted for other inflammatory joint diseases.

Conclusions:

• Reliability and utility of all assessment instruments, especially for low disease activity and remission, require further evaluation.
• Developing measures understandable to both patients and physicians is crucial for improving RA care.
• Continued research aims to refine disease activity assessment for better clinical trial and daily practice application.